<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01917123</url>
  </required_header>
  <id_info>
    <org_study_id>f-91-128</org_study_id>
    <nct_id>NCT01917123</nct_id>
  </id_info>
  <brief_title>The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease</brief_title>
  <official_title>Phase 0 Study of The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease According to Their Smoking History</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masih Daneshvari Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Masih Daneshvari Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized clinical trial before and after study we will assess the effect of
      L-citrulline malate on brachial index in patients with coronary heart disease based on their
      smoking history. Twenty patients with coronary heart disease with no history of diabetes or
      other chronic diseases and with no history of myocardial infarction in the last 6 months will
      participate in our trial.A written well-versed permission was attained from all patients. We
      will measure the brachial index tow times once before giving L-Citrulline malate and the
      other time after 2 weeks giving it.Patients receiving L-Citrulline malate as a 1 gram dry
      powder agent twice a day, that should in use with 250 mg dilute water .The patients will
      followed after 2 weeks by measuring brachial index which is our primary outcome measurement
      in this trial.We assumed that the brachial index in both smoker and non-smoker group of
      patients with coronary heart disease would change to normal or close to normal after giving 1
      gram L-citrulline malate twice a day for 2 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brachial Index</measure>
    <time_frame>2 weeks</time_frame>
    <description>Brachial Index according to the smoking history</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brachial Index</measure>
    <time_frame>2 weeks</time_frame>
    <description>Brachial Index according to coronary heart disease</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Stimol, Brachial Index, Powder agent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>L-Citrulline malate,1gr,twice a day,2weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo, Brachial Index, Powder agent</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo,1gr,twice a day,2weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-Citrulline malate</intervention_name>
    <description>L-Citrulline malate as a 1gr powder agent, twice a day, for 2 weeks and placebo as a 1gr powder agent of O.R.S, twice a day,for 2 weeks</description>
    <arm_group_label>Stimol, Brachial Index, Powder agent</arm_group_label>
    <other_name>Stimol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1- patients with coronary heart disease without history of diabetes or any chronic disease
        2- no myocardial infarction in last 6 months 3-ejection fraction more than 50% 4- please to
        recruit in the trial 5-no uncontrolled blood pressure 6- with stable condition when come to
        the clinic

        Exclusion Criteria:

        1- those who refuse to being in the trial 2- those which their total condition become worse
        3- CCU admission as a result of being unstable 4- patients with chronic heart failure(CHF)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Babak Sharif-Kashani, Cardiologist</last_name>
    <role>Study Director</role>
    <affiliation>Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shabnam Eslam-Panah, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paritash Tahmaseb-pour, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Babak Sharif-Kashani, cardiologist</last_name>
    <phone>0098-021-88883114</phone>
    <email>sharifk@nritld.ac.ir</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paritash Tahmaseb-pour, M.D</last_name>
    <phone>0098-09125037861</phone>
    <email>paritash_t@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital</name>
      <address>
        <city>Tehran</city>
        <zip>021</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Babak Sharif-Kashani, Cardiologist</last_name>
      <phone>0098-021-88883114</phone>
      <email>sharifk@nritld.ac.ir</email>
    </contact>
    <contact_backup>
      <last_name>Paritash Tahmaseb-pour, M.D</last_name>
      <phone>0098-09125037861</phone>
      <email>paritash_t@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Babak har Sharif-Kashani, Cardiologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shabnam Eslam-Panah, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paritash Tahmaseb-pour, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2013</study_first_submitted>
  <study_first_submitted_qc>August 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2013</study_first_posted>
  <last_update_submitted>August 3, 2013</last_update_submitted>
  <last_update_submitted_qc>August 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Masih Daneshvari Hospital</investigator_affiliation>
    <investigator_full_name>babak sharif kashani</investigator_full_name>
    <investigator_title>Head of Cardiology Department</investigator_title>
  </responsible_party>
  <keyword>L-Citrulline malate,Coronary Heart Disease, Brachial Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

